Chinese drugmaker Jiangsu Hengrui Pharmaceuticals has agreed to develop up to 12 of its drugs with British pharmaceutical giant GSK. Hengrui Pharma granted GSK an exclusive worldwide licence to its ...
Alector has confirmed that an alliance with GSK to develop two drug candidates for dementia has been terminated in the wake ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results